Kristine Specht Burk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reimbursement, Incentive | 3 | 2022 | 540 | 0.850 |
Why?
|
| Nipples | 1 | 2020 | 216 | 0.660 |
Why?
|
| Breast Diseases | 1 | 2020 | 443 | 0.600 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 199 | 0.540 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 101 | 0.520 |
Why?
|
| Osteosarcoma | 1 | 2019 | 880 | 0.450 |
Why?
|
| Mammography | 2 | 2020 | 2474 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5249 | 0.410 |
Why?
|
| Calcinosis | 1 | 2020 | 1497 | 0.400 |
Why?
|
| Adnexal Diseases | 2 | 2023 | 102 | 0.400 |
Why?
|
| Radiology | 5 | 2023 | 2090 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 35342 | 0.360 |
Why?
|
| Radiology Information Systems | 2 | 2023 | 523 | 0.310 |
Why?
|
| Preoperative Care | 1 | 2015 | 2245 | 0.280 |
Why?
|
| Tissue Donors | 1 | 2015 | 2205 | 0.280 |
Why?
|
| Prostatic Neoplasms | 3 | 2024 | 11039 | 0.280 |
Why?
|
| Liver Transplantation | 1 | 2015 | 2117 | 0.250 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3507 | 0.240 |
Why?
|
| Krukenberg Tumor | 1 | 2021 | 16 | 0.200 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 20774 | 0.200 |
Why?
|
| Pancreas | 2 | 2018 | 1684 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2023 | 20086 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 3 | 2024 | 2458 | 0.170 |
Why?
|
| Strongylida Infections | 1 | 2018 | 46 | 0.160 |
Why?
|
| Radiology, Interventional | 2 | 2023 | 460 | 0.150 |
Why?
|
| Prostate | 2 | 2024 | 1764 | 0.150 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 250 | 0.150 |
Why?
|
| Retrospective Studies | 15 | 2023 | 77098 | 0.150 |
Why?
|
| Clinical Coding | 1 | 2018 | 171 | 0.140 |
Why?
|
| Image Enhancement | 2 | 2019 | 2921 | 0.140 |
Why?
|
| Peer Group | 1 | 2021 | 635 | 0.140 |
Why?
|
| Abdomen | 1 | 2022 | 1107 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2023 | 4823 | 0.130 |
Why?
|
| Biopsy | 2 | 2024 | 6756 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2019 | 2215 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 1483 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1059 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 594 | 0.100 |
Why?
|
| Humans | 25 | 2024 | 742088 | 0.100 |
Why?
|
| Radiography | 4 | 2023 | 7010 | 0.100 |
Why?
|
| Mastectomy | 1 | 2019 | 1789 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 1095 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3471 | 0.090 |
Why?
|
| Colon | 1 | 2018 | 1773 | 0.090 |
Why?
|
| Checklist | 1 | 2017 | 830 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2187 | 0.090 |
Why?
|
| Contrast Media | 3 | 2019 | 5295 | 0.090 |
Why?
|
| Mass Screening | 3 | 2019 | 5238 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 3070 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 3391 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2021 | 4681 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2023 | 5774 | 0.060 |
Why?
|
| Female | 12 | 2023 | 379592 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4029 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4440 | 0.050 |
Why?
|
| Breast | 2 | 2019 | 1958 | 0.050 |
Why?
|
| Algorithms | 1 | 2020 | 13853 | 0.050 |
Why?
|
| Liver | 1 | 2015 | 7470 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2023 | 5978 | 0.040 |
Why?
|
| Parasitic Diseases | 1 | 2018 | 75 | 0.040 |
Why?
|
| Aged | 5 | 2022 | 162944 | 0.040 |
Why?
|
| Male | 6 | 2024 | 349538 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13655 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 537 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2023 | 1035 | 0.030 |
Why?
|
| Middle Aged | 7 | 2023 | 213127 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2018 | 531 | 0.030 |
Why?
|
| Language | 1 | 2023 | 1458 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 1255 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12958 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2019 | 802 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1183 | 0.020 |
Why?
|
| Program Development | 1 | 2017 | 1314 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2018 | 1365 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1426 | 0.020 |
Why?
|
| Risk Factors | 3 | 2023 | 72145 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2021 | 3527 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3328 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 2542 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2018 | 1904 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8662 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6532 | 0.020 |
Why?
|
| Communication | 1 | 2018 | 3728 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2018 | 4369 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18355 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19862 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 213712 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23320 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53187 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15244 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69693 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57683 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|